[1]
T. Ishida and T. Murayama, “Investigation of the effect of brexpiprazole on acute or relapse schizophrenia using the positive and negative syndrome scale: an experimental report ”, Braz J Case Rep., vol. 2, no. 1, pp. 83–89, Feb. 2022.